John Docherty
Förmögenhet: 1 550 $ per 2026-07-31
Förmögenhet: 1 550 $ per 2026-07-31
John Martin Docherty is currently President, Chief Scientific Officer & Director at Lexaria Bioscience Corp.
since 2015.
Formerly, Mr. Docherty was President & Director at PharmaDerm Laboratories Ltd. from 2004 to 2008 and President & Chief Operating Officer at Helix BioPharma Corp.
from 2007 to 2013.
Education includes undergraduate and graduate degrees from the University of Toronto, conferred in 1993 and 1995 respectively.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
LEXARIA BIOSCIENCE CORP. 0,02 % | 2025-12-01 | 3 963 ( 0,02 % ) | 1 550 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| LEXARIA BIOSCIENCE CORP. | President | 2015-04-15 |
| Företag | Position | Slut |
|---|---|---|
| HELIX BIOPHARMA CORP. | President | 2013-12-01 |
PharmaDerm Laboratories Ltd.
PharmaDerm Laboratories Ltd. Part of Helix BioPharma Corp., PharmaDerm Laboratories Ltd. is a pharmaceutical company based in Saskatoon, Canada. | President | 2008-07-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Helix BioPharma Corp.
Helix BioPharma Corp. Pharmaceuticals: MajorHealth Technology Develops drugs for the prevention and treatment of cancer | Health Technology |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp. Pharmaceuticals: MajorHealth Technology Engages in drug delivery technology | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmaDerm Laboratories Ltd.
PharmaDerm Laboratories Ltd. Part of Helix BioPharma Corp., PharmaDerm Laboratories Ltd. is a pharmaceutical company based in Saskatoon, Canada. |
Välj din utgåva
All finansiell information anpassad till den nationella nivån